Delivery Order SPE2DB22D9316-SPE2DB24FYP30
Award Date 5/31/24
Potential Completion Date 6/3/24
Potential Value $51K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $16,868.68 contract is for the supply of TRUQAP 200 MG TABLET 64S, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. This order is part of a larger single-award indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $16,868.68 firm fixed-price award is for the delivery of TRUQAP 200 MG TABLET 64S to fulfill the recurring pharmaceutical supply needs of military health facilities supported by DLA. The award is not associated with a set-aside program. This delivery order is issued under DMS Pharmaceutical Group's...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $16,868.68, is for the delivery of 4564813182 TRUQAP 200 MG TABLET 64S, a pharmaceutical product, with a completion date of June 4, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999,...
- This is a delivery order award under the Defense Logistics Agency's (DLA) SPE2DB program to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is for the provision of TRUQAP 200 MG TABLET 64S, a pharmaceutical product. The order has a ceiling value of $16,868.68 and a firm fixed-price pricing structure. The award does not have a small business set-aside designation. This single-award indefinite delivery vehicle (IDV)...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,240.32 to DMS Pharmaceutical Group Inc. for the supply of Qulipta 30 mg tablets (30-count units). Issued on July 22, 2025, with an ultimate completion date of July 23, 2025, this firm fixed-price delivery order represents a pharmaceutical supply procurement under DLA's medical logistics operations. The award carries no set-aside designation, and performance will be executed in Park Ridge, Illinois, where the vendor is...
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $19,690.47 firm fixed-price delivery order is for the supply of TRIUMEQ 600-50-300 MG TABLET UU 30S, a specialized pharmaceutical product. The contract is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program. This IDC...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $75,556.44 contract is for the provision of 60 tablets of the pharmaceutical product UPTRAVI 800 MCG. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC, which is valid through November 2026,...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,548.06 contract is for the delivery of UPTRAVI 1,600 MCG tablets to support the recurring medical supply needs of military healthcare facilities. This order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order, valued at $1,240.32, is for the supply of QULIPTA 30 MG TABLET 30S, a pharmaceutical product. The delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group that has a ceiling value of up to $499,999,999 and runs through December 31, 2025. This single-award...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on June 18, 2025, for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $10,656.59 with an ultimate completion date of June 20, 2025, was issued without a set-aside designation. The award falls under the company's larger Indefinite Delivery...
- SPE2DB22D9316Indefinite Delivery Contract
- SPE2DB22D9316-SPE2DB24FYP30Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $50,606.04 firm fixed-price order is for the supply of 4,564,797,696 units of the drug TRUQAP 200 MG TABLET 64S. This order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, which allows the DLA to issue delivery orders for a wide range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation.
Generated 8/30/24, 7:07 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $50.6k | 5/31/24 |